NDC 50090-5139

Ozempic

Semaglutide

Ozempic is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Semaglutide.

• Product ID: 50090-5139_c4869820-1a83-42b5-8ba0-46fa98e373fd
• NDC: 50090-5139
• Product Type: Human Prescription Drug
• Proprietary Name: Ozempic
• Generic Name: Semaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2017-12-06
• Marketing Category: NDA / NDA
• Application Number: NDA209637
• Labeler Name: A-S Medication Solutions
• Substance Name: SEMAGLUTIDE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50090-5139-0

2 SYRINGE, PLASTIC in 1 CARTON (50090-5139-0) > 1.5 mL in 1 SYRINGE, PLASTIC

• Marketing Start Date: 2020-08-31
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Ozempic" or generic name "Semaglutide"

NDC	Brand Name	Generic Name
0169-4130	Ozempic	semaglutide
0169-4132	Ozempic	semaglutide
0169-4136	Ozempic	semaglutide
0169-4181	Ozempic	semaglutide
0169-4772	Ozempic	semaglutide
50090-5138	Ozempic	semaglutide
50090-5139	Ozempic	semaglutide
70518-2143	Ozempic	Ozempic
0169-4501	WEGOVY	semaglutide
0169-4505	WEGOVY	semaglutide
0169-4517	WEGOVY	semaglutide
0169-4524	WEGOVY	semaglutide
0169-4525	WEGOVY	semaglutide